Innopath Therapeutics is redefining the future of care for actinic keratosis and non-melanoma skin cancers — diseases that impact tens of millions of patients across the U.S. and worldwide.
Built on deep scientific and clinical expertise, and a proven track record in topical formulation science, we are developing targeted, patient-friendly therapies designed to overcome the limitations of today’s treatments.
Our approach fills a major therapeutic gap in dermatologic oncology, with the potential to deliver safer, more effective, and accessible solutions — creating lasting impact for patients and meaningful long-term value.
